Cargando…

Targeting DNAJC19 overcomes tumor growth and lung metastasis in NSCLC by regulating PI3K/AKT signaling

BACKGROUND: Some driver oncogenes are still unknown in non-small-cell lung cancer (NSCLC). DNAJC19, a major component of the translocation machinery of mitochondrial membranes, is a disease-associated protein. Herein, we report the role of DNAJC19 in NSCLC cell growth and metastasis. METHODS: Immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Ji, Peng, Yang, Gao, Ying-chun, Chen, Tai-yu, Li, Peng-cheng, Xu, Ke, Liu, Tao, Ren, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254338/
https://www.ncbi.nlm.nih.gov/pubmed/34217321
http://dx.doi.org/10.1186/s12935-021-02054-z
_version_ 1783717709405487104
author Zhou, Ji
Peng, Yang
Gao, Ying-chun
Chen, Tai-yu
Li, Peng-cheng
Xu, Ke
Liu, Tao
Ren, Tao
author_facet Zhou, Ji
Peng, Yang
Gao, Ying-chun
Chen, Tai-yu
Li, Peng-cheng
Xu, Ke
Liu, Tao
Ren, Tao
author_sort Zhou, Ji
collection PubMed
description BACKGROUND: Some driver oncogenes are still unknown in non-small-cell lung cancer (NSCLC). DNAJC19, a major component of the translocation machinery of mitochondrial membranes, is a disease-associated protein. Herein, we report the role of DNAJC19 in NSCLC cell growth and metastasis. METHODS: Immunohistochemistry (IHC) was performed to investigate DNAJC19 expression in NSCLC clinical samples. For knockdown or overexpression assays in A549 or NCI-H1299 lung cancer cells, lentiviral vectors were used. After assessment of cell functions, DNAJC19-knockdown A549 cells were further applied to establish mouse xenograft and metastasis tumor models. Assessments based on the RNA-seq data, western blotting, PCR and IHC were performed for the mechanistic study. RESULTS: Expression of DNAJC19 was higher in tumors than in noncancerous adjacent tissues. Survival analysis indicated that low DNAJC19 levels were correlated with an increased progression-free survival rate. ShRNA-mediated knockdown of DNAJC19 markedly inhibited cell growth, viability, migration and invasion. Moreover, RNA-seq analysis revealed that the PI3K/AKT signaling pathway was involved in molecular events when A549 cells were treated with shDNAJC19. In addition, DNAJC19 knockdown decreased PI3Kp85a, AKT and p-AKT expression in A549 cells, and cellular functions were greatly rescued in DNAJC19-knockdown A549 cells by ectopic overexpression of AKT. Furthermore, tumor xenograft growth and lung metastasis were markedly repressed in the shDNAJC19 group compared to the control group. As expected, the expression levels of DNAJC19, PI3K and AKT in xenograft mouse samples were also lower in the shDNAJC19 group than in the shCtrl group. CONCLUSIONS: DNAJC19 greatly promotes NSCLC cell growth and lung metastasis by regulating PI3K/AKT signaling, providing a novel therapeutic target for treating NSCLC patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-021-02054-z.
format Online
Article
Text
id pubmed-8254338
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82543382021-07-06 Targeting DNAJC19 overcomes tumor growth and lung metastasis in NSCLC by regulating PI3K/AKT signaling Zhou, Ji Peng, Yang Gao, Ying-chun Chen, Tai-yu Li, Peng-cheng Xu, Ke Liu, Tao Ren, Tao Cancer Cell Int Primary Research BACKGROUND: Some driver oncogenes are still unknown in non-small-cell lung cancer (NSCLC). DNAJC19, a major component of the translocation machinery of mitochondrial membranes, is a disease-associated protein. Herein, we report the role of DNAJC19 in NSCLC cell growth and metastasis. METHODS: Immunohistochemistry (IHC) was performed to investigate DNAJC19 expression in NSCLC clinical samples. For knockdown or overexpression assays in A549 or NCI-H1299 lung cancer cells, lentiviral vectors were used. After assessment of cell functions, DNAJC19-knockdown A549 cells were further applied to establish mouse xenograft and metastasis tumor models. Assessments based on the RNA-seq data, western blotting, PCR and IHC were performed for the mechanistic study. RESULTS: Expression of DNAJC19 was higher in tumors than in noncancerous adjacent tissues. Survival analysis indicated that low DNAJC19 levels were correlated with an increased progression-free survival rate. ShRNA-mediated knockdown of DNAJC19 markedly inhibited cell growth, viability, migration and invasion. Moreover, RNA-seq analysis revealed that the PI3K/AKT signaling pathway was involved in molecular events when A549 cells were treated with shDNAJC19. In addition, DNAJC19 knockdown decreased PI3Kp85a, AKT and p-AKT expression in A549 cells, and cellular functions were greatly rescued in DNAJC19-knockdown A549 cells by ectopic overexpression of AKT. Furthermore, tumor xenograft growth and lung metastasis were markedly repressed in the shDNAJC19 group compared to the control group. As expected, the expression levels of DNAJC19, PI3K and AKT in xenograft mouse samples were also lower in the shDNAJC19 group than in the shCtrl group. CONCLUSIONS: DNAJC19 greatly promotes NSCLC cell growth and lung metastasis by regulating PI3K/AKT signaling, providing a novel therapeutic target for treating NSCLC patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-021-02054-z. BioMed Central 2021-07-03 /pmc/articles/PMC8254338/ /pubmed/34217321 http://dx.doi.org/10.1186/s12935-021-02054-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Primary Research
Zhou, Ji
Peng, Yang
Gao, Ying-chun
Chen, Tai-yu
Li, Peng-cheng
Xu, Ke
Liu, Tao
Ren, Tao
Targeting DNAJC19 overcomes tumor growth and lung metastasis in NSCLC by regulating PI3K/AKT signaling
title Targeting DNAJC19 overcomes tumor growth and lung metastasis in NSCLC by regulating PI3K/AKT signaling
title_full Targeting DNAJC19 overcomes tumor growth and lung metastasis in NSCLC by regulating PI3K/AKT signaling
title_fullStr Targeting DNAJC19 overcomes tumor growth and lung metastasis in NSCLC by regulating PI3K/AKT signaling
title_full_unstemmed Targeting DNAJC19 overcomes tumor growth and lung metastasis in NSCLC by regulating PI3K/AKT signaling
title_short Targeting DNAJC19 overcomes tumor growth and lung metastasis in NSCLC by regulating PI3K/AKT signaling
title_sort targeting dnajc19 overcomes tumor growth and lung metastasis in nsclc by regulating pi3k/akt signaling
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254338/
https://www.ncbi.nlm.nih.gov/pubmed/34217321
http://dx.doi.org/10.1186/s12935-021-02054-z
work_keys_str_mv AT zhouji targetingdnajc19overcomestumorgrowthandlungmetastasisinnsclcbyregulatingpi3kaktsignaling
AT pengyang targetingdnajc19overcomestumorgrowthandlungmetastasisinnsclcbyregulatingpi3kaktsignaling
AT gaoyingchun targetingdnajc19overcomestumorgrowthandlungmetastasisinnsclcbyregulatingpi3kaktsignaling
AT chentaiyu targetingdnajc19overcomestumorgrowthandlungmetastasisinnsclcbyregulatingpi3kaktsignaling
AT lipengcheng targetingdnajc19overcomestumorgrowthandlungmetastasisinnsclcbyregulatingpi3kaktsignaling
AT xuke targetingdnajc19overcomestumorgrowthandlungmetastasisinnsclcbyregulatingpi3kaktsignaling
AT liutao targetingdnajc19overcomestumorgrowthandlungmetastasisinnsclcbyregulatingpi3kaktsignaling
AT rentao targetingdnajc19overcomestumorgrowthandlungmetastasisinnsclcbyregulatingpi3kaktsignaling